Integrated Filing — IndAS



General information about company
Scrip Code 543271
NSE Symbol JUBLINGREA
MSEI Symbol NOTLISTED
ISIN INE0BY001018
Name of company JUBILANT INGREVIA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 31-Jul-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 31-Jul-2025   10:30:00
End date and time of board meeting 31-Jul-2025   13:15:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 10379500000
Other income 112200000
Total income 10491700000
2 Expenses
(a) Cost of materials consumed 4489100000
(b) Purchases of stock-in-trade 324000000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 381300000
(d) Employee benefit expense 1082300000
(e) Finance costs 126900000
(f) Depreciation, depletion and amortisation expense 408400000
(f) Other Expenses
1 Power and fuel expense 999600000 999600000
2 Others 1681800000 1681800000
Total other expenses 2681400000
Total expenses 9493400000
3 Total profit before exceptional items and tax 998300000
4 Exceptional items 0
5 Total profit before tax 998300000
6 Tax expense
7 Current tax 231700000
8 Deferred tax 15000000
9 Total tax expenses 246700000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 751600000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method -600000
16 Total profit (loss) for period 751000000
17 Other comprehensive income net of taxes 100700000
18 Total Comprehensive Income for the period 851700000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 751000000
Total profit or loss, attributable to non-controlling interests 0
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 851700000
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0
21 Details of equity share capital
Paid-up equity share capital 158100000
Face value of equity share capital 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.75
Diluted earnings (loss) per share from continuing operations 4.75
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.75
Diluted earnings (loss) per share from continuing and discontinued operations 4.75
24 Debt equity ratio 0.0023
25 Debt service coverage ratio 0.0472
26 Interest service coverage ratio 0.1208
27 Disclosure of notes on financial results



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Speciality Chemicals 5369700000 5369700000
2 Nutrition & Health Solutions 1788700000 1788700000
3 Chemical Intermediates 3816500000 3816500000
Total Segment Revenue 10974900000
Less: Inter segment revenue 595400000 595400000
Revenue from operations 10379500000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Speciality Chemicals 1062300000 1062300000
2 Nutrition & Health Solutions 199900000 199900000
3 Chemical Intermediates 49700000 49700000
Total Profit before tax 1311900000
i. Finance cost 126900000 126900000
ii. Other Unallocable Expenditure net off Unallocable income 187300000 187300000
Profit before tax 997700000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Speciality Chemicals 28805600000 28805600000
2 Nutrition & Health Solutions 7941800000 7941800000
3 Chemical Intermediates 14760700000 14760700000
Total Segment Asset 51508100000 51508100000
Un-allocable Assets 2274600000 2274600000
Net Segment Asset 53782700000 53782700000
4 Segment Liabilities
Segment Liabilities
1 Speciality Chemicals 6122600000 6122600000
2 Nutrition & Health Solutions 1577000000 1577000000
3 Chemical Intermediates 4995300000 4995300000
Total Segment Liabilities 12694900000 12694900000
Un-allocable Liabilities 10937700000 10937700000
Net Segment Liabilities 23632600000 23632600000
Disclosure of notes on segments



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss 16000000 16000000
Total Amount of items that will not be reclassified to profit and loss 16000000
2 Income tax relating to items that will not be reclassified to profit or loss 1600000
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit or loss 117900000 117900000
Total Amount of items that will be reclassified to profit and loss 117900000
4 Income tax relating to items that will be reclassified to profit or loss 31600000
5 Total Other comprehensive income 100700000